The digital breast tomosynthesis (DBT) market continues to evolve, with reportedly no less than six new systems prepping to hit the market in the near future. At the 2015 Radiological Society of North America (RSNA) annual meeting, Liane Philpotts, M.D., professor of diagnostic radiology and chief of breast imaging at Yale University, discussed how tomosynthesis is revolutionizing breast imaging.

Like with many other aspects of healthcare, technology has been the driving force behind the evolution of radiation therapy. New advancements have given rise to new, more precise techniques for delivering maximum radiation dose to tumor volumes with minimum effect to surrounding tissue.

Ultrasound imaging took some major steps forward in 2015, with innovative new systems and technologies debuting across multiple market segments. From new premium-tier systems to the expansion of handheld, point-of-care (POC) solutions, vendors focused on improvements in image quality, productivity and ergonomics — “all those things the customers need to do quality work, diagnostics work at a rapid pace,” said Jon Brubaker, MBA, RCVT, ultrasound technology analyst for MD Buyline.